Treating Depression During Pregnancy May Benefit Babies' Brain Development

A randomized trial examines the relationship between maternal mental-health treatment and early infant development.

Research reported by Medical Xpress on 16 October found that treating depression during pregnancy may influence infant brain development and early emotional functioning. The findings highlight the importance of addressing maternal mental health during pregnancy.

Reported by: System Admin
•
October 18, 2026
•
5 min read
Dr. Arvind Deshmukh

MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH

Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute

Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Treating Depression During Pregnancy May Benefit Babies' Brain Development
Photo: Clinical Archives / HealthGhuru EditorialVerified Creative Rights

Depression during pregnancy can affect a woman's emotional wellbeing, sleep, appetite and ability to manage daily activities. It can also make it harder to access prenatal care and maintain supportive routines. Researchers are investigating whether effective treatment during pregnancy may have benefits extending beyond the mother's symptoms. The reported randomized trial examined maternal depression treatment and outcomes related to infants' brain development and early emotional functioning. The findings suggest that maternal mental-health care may be relevant to the early developmental environment in which babies grow. The results should not be interpreted as proof that depression treatment guarantees a particular developmental outcome for every child. The type of treatment, severity of depression, timing, family support and other health factors can all matter. Pregnant women experiencing persistent sadness, anxiety, loss of interest, hopelessness or difficulties functioning should speak with an obstetrician or mental-health professional. Treatment decisions—including psychotherapy and medication where appropriate—should be individualized rather than based on fear or stigma.

Story Photo Gallery

Photo 1
Dr. Arvind Deshmukh

Dr. Arvind Deshmukh

VERIFIED

Cardiologist & Electrophysiologist

Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.

Scientific References & Journal Citations

  1. National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
  2. Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
  3. European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.

Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.